Open Access
ARTICLE
Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula
1
Division of Urology/Department of Surgery, University of California San Diego School of Medicine, La Jolla, California, USA
2
Surgical Service, San Diego Veterans Administration Medical Center, La Jolla, California, USA
3
Department of Radiology, University of California San Diego School of Medicine, La Jolla, California, USA
4
Radiology Service, San Diego Veterans Administration Medical Center, La Jolla, California, USA
Address correspondence to Dr. Ithaar H. Derweesh, Division
of Urology, Moores UCSD Cancer Center, 3855 Health Sciences
Drive, Mail Code: 0987, La Jolla, CA 92093-0987, USA
Canadian Journal of Urology 2013, 20(3), 6790-6797.
Abstract
Introduction: To further elucidate potential patterns of contrast enhancement for renal neoplasm subtypes, we investigated the utility of a contrast washout formula to differentiate renal tumor histology after multiphase computerized tomography (CT).Materials and methods: A single-center retrospective cohort study of 163 patients with multiphase CT for renal masses obtained from October 2007 to July 2012. Pathology confirmed clear cell renal cell carcinoma (CC-RCC; n = 92), papillary (Pa-RCC; n = 43), chromophobe (Ch-RCC; n = 6), oncocytoma (OC; n = 11), or angiomyolipoma (AML; n = 11) histology. Two radiologists in consensus, blinded to histology, recorded tumor size, morphology, and attenuation measurements in Hounsfield Units (HU). Data were analyzed between subgroups based on histology. Enhancement washout of the tumor was calculated by the formula: (Mass nephrographic HU - Mass delayed HU) / (Mass nephrographic HU - Mass non-contrast HU), and used to calculate sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).
Results: Tumor size was largest among CC-RCC (p < 0.001). Homogeneous composition was more common among Pa-RCC and Ch-RCC (p < 0.001). Median washout for Ch-RCC (0.27) was significantly different from that of OC (0.54, p = 0.05). Overall, 25 (15.3%) of tumors had washout < 0. Tumors with washout value < 0 included Pa-RCC 24/43 (56%), and Ch-RCC 1/6 (14%). Washout value < 0 had a specificity of 99.2% for Pa-RCC and 100% for non-CC-RCC. Washout value ≥ 0 had a sensitivity and NPV of 100% for CC-RCC, OC, and AML. Washout value ≥ 0 had a specificity of 35.2% and a PPV of 66.7% for CC-RCC.
Conclusions: Enhancement washout value < 0 is highly specific for Pa-RCC and non-CC-RCC. Washout value ≥ 0 is highly sensitive for CC-RCC, OC, and AML, while there was a significant difference in median washout between OC and Ch-RCC. Further prospective investigation is requisite to confirm these findings.
Keywords
Cite This Article
Copyright © 2013 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Submit a Paper
Propose a Special lssue
Download PDF
Downloads
Citation Tools